Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/the-heart-in-systemic-autoimmune-diseases/descriptif_3781477
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3781477

The Heart in Systemic Autoimmune Diseases (2nd Ed.) Handbook of Systemic Autoimmune Diseases Series

Langue : Anglais

Coordonnateurs : Atzeni Fabiola, Dorea Andrea, Nurmohamed Mike, Pauletto Paolo

Couverture de l’ouvrage The Heart in Systemic Autoimmune Diseases

The Heart in Systemic Autoimmune Diseases, Second Edition, provides an overview on our current understanding of major complications relating to the heart and autoimmune diseases. It includes the latest information on the new pathogenetic mechanisms involved, along with clinical manifestations of these important comortbidities. Mortality in autoimmune diseases, in particular, rheumatoid arthritis and SLE, has increased when compared with the general population. This excess mortality is largely due to cardiovascular diseases (CVDs)-particularly those of atherosclerotic origin, such as ischemic heart disease-and is gaining recognition in all branches of medicine, from cardiology, to internal medicine, and from rheumatologists to orthopedics.

1. Cellular Immunity: A Role for Cytokines 2. Organ-Specific Autoimmunity Involvement in Cardiovascular Disease 3. Neonatal Lupus Syndromes: Pathogenesis and Clinical Features 4. Subclinical Cardiovascular Damage in Systemic Rheumatic Diseases 5. Atherosclerosis and Autoimmunity 6. Inflammasomes and Inflammatory Cytokines in Early Atherosclerosis 7. Treatment of Lipid Metabolism Disturbances in Autoimmune Diseases 8. Cardiac Imaging Techniques in Systemic Autoimmune Diseases 9. New Cardiac Imaging Tools and Invasive Techniques in Systemic Autoimmune Diseases (Part II) 10. Cardiac Diseases in Rheumatoid Arthritis 11. Cardiac Involvement in Systemic Lupus Erythematosus 12. Cardiac Involvement in the Antiphospholipid Syndrome 13. Cardiac Involvement in Scleroderma 14. Cardiac Involvement in Systemic Vasculitis 15. Cardiovascular Involvement in Ankylosing Spondylitis 16. Cardiovascular Involvement in Psoriatic Arthritis 17. Cardiovascular Involvement in Primary Sjögren's Syndrome 18. Gout and Heart Disease: A Two-Way Street? 19. Heart Involvement in Osteoarthritis 20. Cardiac Effects of Antirheumatic Drugs

Fabiola Atzeni, MD, PhD is currently Full Professor and Head of the Rheumatology Unit, University of Messina, Messina, Italy. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has co-authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals. She is involved in several international and national meetings focused on cardiovascular and infection aspects.

Professor Doria received his medical degree and qualification in Rheumatology from the University of Padua. He was Council member of Italian College of Rheumatology (CRO) between 1999 and 2005 and a Council member of Italian Society of Rheumatology (SIR) from 2007 to 2010 and from 2013 up to now. He is also a member of American College of Rheumatology (ACR).

Professor Doria has organised over ten international conferences on autoimmunity and was involved as “expert” in the EUropean League Against Rheumatism (EULAR) Standing Committee for the development of clinical and therapeutic recommendations: (1) EULAR recommendations for the management of systemic lupus erythematosus (SLE)—Assessment of the SLE patient (2008–2009); (2) EULAR recommendations for the management of SLE Part II—Neuropsychiatric disease (2008–2009); (3) Joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (2012). Professor Doria is a member of the Lupus Academy Steering Committee co-Chaired the 4th Annual Meeting held in Rome 27th February to 1st March 2015. He will also chair the 10th European Lupus Meeting which will be

  • Presents an impressive body of well ordered information on the topic of cardiovascular diseases and their relationship to autoimmune illness
  • Highlights key references
  • Summarizes the experience of a selected panel of distinguished physician-scientists who are actively involved in the field of cardiovascular disease and systemic autoimmunity

Date de parution :

Ouvrage de 566 p.

15x22.8 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

144,35 €

Ajouter au panier

Thèmes de The Heart in Systemic Autoimmune Diseases :

Mots-clés :

2-Glycoprotein-I; 2GPI; Antibodies; Anticardiolipin antibodies; Anti-heart autoantibodies; Antiphospholipid syndrome; Antiphospholipid; Antirheumatic drug; Antirheumatic drugs; Anti-Ro/SSA antibodies; Aortitis; Apolipoprotein; Arterioles; AS; Atherosclerosis; Atherosclerotic cardiovascular diseases; Autoantibodies; Autoimmune disease; Autoimmune; Autoimmunity; AV block; Biologics; Cardiac involvement; Cardiovascular disease; Cardiovascular imaging; Cardiovascular involvement; Cardiovascular risk assessment; Cardiovascular risk management; Case-control studies; Congenital heart block; Coronaritis; Coronary disease; Cytokines; Diagnosis; Dilated cardiomyopathy; Dyslipidemia; Dysregulation; Echocardiography; Endocardial fibroelastosis; Endocardium; Extraglandular; Gout; Heart valve lesions; Heart; Heat-shock protein; HSP; Hybridization; Hydroxychloroquine; Hypertension; Inflammaging; Inflammasomes; Inflammation; Inflammatory disease; Innate immunity; Ischemia; Lipid metabolism; Lipoprotein; Lupus anticoagulant; Meta-analysis; Metabolic disease; Metabolism; Mortality; Myocardial infarction; Myocarditis; Myocardium; Myocytes; Natural killer; Neonatal lupus; Nonatherosclerotic cardiovascular disease; Nutraceuticals; Oxidized LDL; oxLDL; Pathogenesis; Pathogens; Pericardial effusion; Plasma asymmetric dimethylarginine; Psoriatic arthritis; Radiation therapy; Raynaud phenomenon; Rheumatic disease; Rheumatoid arthritis; Sarcoidosis; Subchondral bone; Systemic lupus erythematosus; Systemic vasculitis; Treatment; Tumor necrosis factor; Ultrasonography; Valsalva; Valvular